Sign in

CIK 0001710072

  • Large accelerated filer

Edgewise Therapeutics, Inc.

Sign in to watch
Ticker
EWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821725586
Phone
+1 720-262-7002
Business address
1715 38TH ST, BOULDER, CO, 80301
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale CMO sold 55,230 shares at an average $37.88 ($2,092,063)
  4. 4 Grant or award Director acquired 339 shares (grant or award)
  5. 4 Planned sale CMO sold 28,662 shares at $32.31 ($926,095)
  6. 4 Planned sale CMO sold 21,338 shares at $32.12 ($685,308)
  7. 4 Planned sale CMO sold 16,358 shares at $30.98 ($506,735)
  8. 4 Planned sale Director sold 115,471 shares at $29.44 ($3,399,466)
  9. 4 Grant or award Director acquired 473 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale Chief Scientific Officer sold 100,000 shares at $21.12 ($2,112,450)
  13. 4 Open-market buy Director bought 10,700 shares at $18.64 ($199,403)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award Director acquired 728 shares (grant or award)
  17. 4 Open-market sale Chief Scientific Officer sold 100,000 shares at $14.60 ($1,459,760)
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale General Counsel sold 2,098 shares at $13.39 ($28,097)
  20. 4 Open-market sale Chief Business Officer sold 2,491 shares at $13.39 ($33,360)

Page 2 of 11 · 202 filings